ZJULLi002-A, 161103SPYLQTFSDC12

General

Cell Line

hPSCreg name ZJUi010-A
Cite as:
ZJUi010-A (RRID:CVCL_C0IJ)
Alternative name(s)
ZJULLi002-A, 161103SPYLQTFSDC12
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
ITXi003-A
(MS368)
Donor diseases:
Long QT Syndrome
SCVIi061-A
(SCVI2149C1)
Donor diseases:
Long QT Syndrome
SCVIi062-A
(SCVI2150c1)
Donor diseases:
Long QT Syndrome
YUCMi022-A
(hiPSC-KCNH2_G53S)
Donor diseases:
Long QT Syndrome
ITXi004-A
(MS381)
Donor diseases:
Long QT Syndrome
CBRCULi016-A
(SCN5A p.R219H-14C)
Donor's gene variants:
SCN5A
Donor diseases:
dilated cardiomyopathy
HDZi003-A
(hiPSC NP0038)
Donor's gene variants:
TMEM43
Donor diseases:
arrhythmogenic right ventricular dysplasia 5
UMCGi009-A
(PLN2-C2)
Donor diseases:
Cardiomyopathy
UMCGi003-A
(PPCM RP1 c1)
Donor diseases:
peripartum cardiomyopathy
UMCGi003-B
(PPCM RP1 c3)
Donor diseases:
peripartum cardiomyopathy
UMCGi005-A
(PPCM RP2 c2)
Donor diseases:
peripartum cardiomyopathy
UMCGi005-B
(PPCM RP2 c9)
Donor diseases:
peripartum cardiomyopathy
IDIBGIi003-A
(​RB20235)
Donor diseases:
Brugada syndrome
Last update 12th May 2022
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Zhejiang University (ZJU)
Owner Zhejiang University Lianglab (ZJULL)
Distributors
Derivation country China

External Databases

BioSamples SAMEA14091364
Cellosaurus CVCL_C0IJ
Wikidata Q112930592

General Information

Publications
* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Ethnicity Chinese Han

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Ventricular arrhythmia associated with long QT syndrome
  • Long QT Syndrome
  • LONG QT SYNDROME

Karyotyping (Donor)

Has the donor karyotype been analysed?
Yes

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA14091365

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Please provide contact information of the holder of the original Donor Information Sheet. 17761703769@163.com
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
How may genetic information associated with the cell line be accessed? Open Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Approval from the First Affiliated Hospital Zhejiang University School of Medicine Review Board was obtained.
Approval number No. 2015-147
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

Source cell type
Synonyms
  • fibroblast
  • Fibroblasts
  • Fibroblast
  • FIBROBLAST
show more synonyms

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
No
Methods used
PCR, Sequencing

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
Yes

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SSEA-4
Yes
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
Score:
Marker Present Absent
mCpG
OCT4
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vivo teratoma
Mesoderm
Ont Id: UBERON_0000926
In vivo teratoma
Ectoderm
Ont Id: UBERON_0000924
In vivo teratoma

Microbiology / Virus Screening

Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes

Other Genotyping (Cell Line)